Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Congenital Myasthenic Syndrome”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Not applicableStudy completedNCT01474980
What this trial is testing

Pregnancy Outcomes in Congenital Myasthenie Syndrome

Who this might be right for
Congenital Myasthenic Syndrome
Institut de Myologie, France 25
Not applicableLooking for participantsNCT06630650
What this trial is testing

A Prospective Natural History and Outcome Measure Validation Study of Congenital Myasthenic Syndromes

Who this might be right for
Myasthenic Syndromes, Congenital
National Institute of Neurological Disorders and Stroke (NINDS) 75
Not applicableEnrolling By InvitationNCT07072676
What this trial is testing

The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.

Who this might be right for
Inclusion Body MyositisMyotonic Dystrophy 1Myotonic Dystrophy 2+10 more
LMU Klinikum 30
Not applicableLooking for participantsNCT06078553
What this trial is testing

A Natural History Study in Participants With Congenital Myasthenic Syndromes (CMS) Due to Mutations in DOK7, MUSK, AGRN, or LRP4

Who this might be right for
Congenital Myasthenic Syndrome
argenx 100
Large-scale testing (Phase 3)Study completedNCT02562066
What this trial is testing

Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes

Who this might be right for
Myasthenic Syndromes, Congenital
Catalyst Pharmaceuticals, Inc. 20
Not applicableLooking for participantsNCT07136844
What this trial is testing

Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology

Who this might be right for
Neuromuscular DiseasesObesity (Disorder)Myotonic Dystrophy 1+9 more
Centre Hospitalier Universitaire de Liege 300
Not applicableNo Longer AvailableNCT02012933
What this trial is testing

3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome (LEMS) and Congenital Myasthenia (CM)

Who this might be right for
Lambert-Eaton Myasthenic Syndrome (LEMS)Congenital Myasthenia (CM)
Oregon Health and Science University
Not applicableStudy completedNCT05687474
What this trial is testing

Baby Detect : Genomic Newborn Screening

Who this might be right for
Congenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more
Centre Hospitalier Universitaire de Liege 6,824
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Not applicableUnknownNCT02124616
What this trial is testing

National Registry for Egyptian Pediatric Neuromuscular Diseases

Who this might be right for
Spinal Muscular AtrophyMuscular DystrophyMuscle Diseases+2 more
Ain Shams University 200
Early research (Phase 1)Active Not RecruitingNCT06436742
What this trial is testing

A Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Participants With DOK7-Congenital Myasthenic Syndromes (CMS)

Who this might be right for
Congenital Myasthenic SyndromeCMS
argenx 15
Not applicableApproved For MarketingNCT00872950
What this trial is testing

3,4-Diaminopyridine Use in Lambert-Eaton Myasthenic Syndrome(LEMS) and Congenital Myasthenic Syndromes (CMS)

Who this might be right for
Lambert-Eaton Myasthenic SyndromeCongenital Myasthenic Syndrome
Lahey Clinic
Not applicableLooking for participantsNCT07478172
What this trial is testing

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease

Who this might be right for
Neuromuscular Diseases (NMD)Amyotrophic Lateral SclerosisMyasthenia Gravis+15 more
University of Missouri-Columbia 50
Not applicableStudy completedNCT05408702
What this trial is testing

Exercise in Autoimmune Myasthenia Gravis and Myasthenic Syndromes

Who this might be right for
Autoimmune Myasthenia GravisLambert-Eaton Myasthenic SyndromeCongenital Myasthenic Syndrome+1 more
Institut de Myologie, France 500
Not applicableEnrolling By InvitationNCT06605612
What this trial is testing

Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders

Who this might be right for
Inclusion Body MyositisMyotonic DystrophyLimb-girdle and Facioscapulohumeral Muscular Dystrophies+9 more
LMU Klinikum 108
Large-scale testing (Phase 3)Not Yet RecruitingNCT07746089
What this trial is testing

Assess Efficacy and Safety of Adimanebart in Adult and Pediatric Participants With DOK7-,MUSK-, AGRN-, or LRP4- Congenital Myasthenic Syndromes (CMS)

Who this might be right for
Congenital Myasthenic SyndromeCMS
argenx 105
Not applicableApproved For MarketingNCT02189720
What this trial is testing

Expanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS),Congenital Myasthenic Syndrome

Who this might be right for
Congenital Myasthenic SyndromeLambert-Eaton Myasthenic SyndromeNystagmus, Acquired
Catalyst Pharmaceuticals, Inc.
Early research (Phase 1)Not Yet RecruitingNCT07830563
What this trial is testing

Evaluating the Safety and Effects of AMP-101 in People With DOK7 Congenital Myasthenia Syndrome

Who this might be right for
Congenital Myasthenia Syndrome
Amplo Biotechnology 4
Early research (Phase 1)Looking for participantsNCT07226726
What this trial is testing

Patients With Congenital Myasthenic Syndrome Will be Treated With Mesenchymal Stem Cell Exosome Solution

Who this might be right for
Congenital Myasthenic Syndrome
The Foundation for Orthopaedics and Regenerative Medicine 20
Early research (Phase 1)Study completedNCT01203592
What this trial is testing

Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes

Who this might be right for
Congenital Myasthenic Syndrome
Mayo Clinic 21
Next Page